Source: Annual Congress 2012 - New aspects of lung cancer biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ilouze, N. Peled (Ramat-Gan, Israel). Glycolytic phenotype mapping in lung cancer cell lines. Eur Respir J 2012; 40: Suppl. 56, 1220

Member's Comments

No comment yet.

Related content which might interest you: Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: ERS Lung Science Conference 2017 Year: 2017 The influence of conventional and targeted chemotherapy on the expression of stem cell markers in lung cancer cell lines Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 The influence of brown adipose tissue on the proliferation and chemosensitivity in non-small cell lung cancer cells Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Dopaminergic markers in human small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 231s Year: 2002 Functional consequences of cathepsin L-deficiency in the human lung carcinoma cell line A549 Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Clinical implication of stem cell markers in N2 positive non-small cell lung cancer Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Expression of RASGRF2 in non-small cell lung cancer and its effect of transfection on biological behavior of human NSCLC lines H1299 Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Are there any peculiarities in tumour behavior and different tumour markers expression in nonsmall cell lung cancer? Source: Eur Respir J 2001; 18: Suppl. 33, 232s Year: 2001 Nonsmall cell lung cancer Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I Year: 2012 The expression and biological significance of PD-L1 on lung cancer cell lines Source: Annual Congress 2009 - Lung cancer biology Year: 2009 The influence of erythropoietin on growth and survival in non-small cell lung cancer cell lines Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006 Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004 Choice of endogenous control for gene expression in nonsmall cell lung cancer Source: Eur Respir J 2005; 26: 1002-1008 Year: 2005 IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer Source: Eur Respir J , 49 (4)  1600711; DOI: 10.1183/13993003.00711-2016 Year: 2017 LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016